A UK coroner’s inquest has linked the death of British-Nigerian influencer Igho “Tiny” Ubiribo to a cosmetic filler injection he received at a clinic in Bangkok. The clinic has not been named. No accreditation scheme, ranking or medical visa programme covers the kind of place he walked into.
Key takeaways
- An inquest at Inner West London Coroners’ Court heard that 40 millilitres of hyaluronic acid and lidocaine, injected on 5 March, caused the pulmonary embolism that killed Ubiribo the following morning. He was 43.
- A UK post-mortem found material in his lungs consistent with the filler. That finding, not the press coverage, is the evidentiary spine of this story.
- He did not fly to Thailand for treatment. He was on holiday, decided during the trip, and was treated within the hour and dead within the day.
- Thailand’s international patient reputation rests on 63 internationally accredited hospitals. Its exposure sits in the aesthetic clinics that no accreditation body inspects and no ranking lists.
What the inquest heard
Igho Ubiribo did not travel to Thailand for surgery. He travelled for a holiday.
He and his wife were staying at a Marriott hotel in Bangkok. On 5 March he went to a clinic and had 40 millilitres of hyaluronic acid and lidocaine injected into his penis. Afterwards the couple went for a massage. He began complaining of chest pain. He lost consciousness twice.
An ambulance took him to Sukhumvit Hospital. He was awake on arrival and able to tell doctors what he had just had done. Then he passed out again, before a CT scan could be performed. Doctors diagnosed a pulmonary embolism — a blockage in the blood vessels of the lungs — and moved him to intensive care. CPR was carried out for more than 100 minutes. He died in the early hours of 6 March.
Six months later, an inquest at Inner West London Coroners’ Court heard the rest. A post-mortem examination in the UK found material in his lungs consistent with the filler used in the procedure. The court was told the injected substances caused the embolism.
He died on 6 March. The medical travel industry found out on 5 September, when the New York Post reported the inquest and the story moved through Thai, British and Nigerian outlets within 48 hours. No Thai regulator announced the death. No facilitator flagged it, because no facilitator was involved. No accreditation body had reason to know.
The procedure is not the outlier
Penile girth enhancement with hyaluronic acid is published, regulated where it is performed properly, and increasingly routine. It is not fringe medicine.
A 2025 review in Translational Andrology and Urology found that hyaluronic acid, used under standardised low-volume protocols, carries lower complication rates than polylactic acid, PMMA, silicone or the substances men inject into themselves. A retrospective review of 471 patients at a single US clinic, presented at the American Urological Association’s 2024 meeting, recorded two injection-site infections and three granulomas. All resolved without surgery.
The volume is what stands out. A prospective Korean trial published in the Journal of Sexual Medicine used a mean injected volume of 20.56cc, across a range of 18 to 22. Practitioners working to the better-documented protocols inject small amounts across sessions spaced weeks apart, because the tissue is vascular and the material has nowhere safe to go if it enters a vessel.
Ubiribo received 40 millilitres in one appointment. Roughly double the published mean, in a single sitting. Whether that is what killed him is for the coroner’s full findings to establish.
Filler embolism is a known catastrophic failure in aesthetic medicine. In facial work it causes sudden blindness and neurological injury when material enters an artery and travels. Technique, injection plane and injector training decide whether that happens. The product on the shelf does not.
Thailand’s two markets
The hospital tier is well documented. Sixty-three Thai medical institutions held Joint Commission International accreditation as of February 2025. Bumrungrad, Samitivej and the BDMS network have decades of international patient experience and published outcomes. The Royal Thai Embassy in Washington puts the country’s 2023 volume at roughly 2.86 million international patients, generating around $850 million.
Beneath that sits a market with no equivalent paper trail: aesthetic clinics selling injectables to locals and tourists at the same counter, advertised on Instagram and Facebook, bookable the same week.
Enforcement exists. It is also outmatched. In late June, the Consumer Protection Police Division and the Department of Health Service Support raided two houses in Bangkok’s Bueng Kum district and in Samut Prakan that had been converted into cosmetic clinics. Officers found a 31-year-old woman injecting Botox into a client’s face. She held no medical licence. She told police she had learned by watching doctors during six or seven years working in cosmetic clinics, then spent two years running her own service, advertising packages from 790 baht on Facebook and treating two to five customers a day. Police seized more than 1,100 medical products and pieces of equipment.
Those raids show a functioning enforcement mechanism. They also show its scale problem: hundreds of small operators, low prices, social distribution, and customers who do not classify an injection as surgery.
There is no public indication that the clinic Ubiribo visited was unlicensed, and it has not been named.
Britain’s case file
For UK readers this lands on a stack that has been building for a decade.
The Foreign, Commonwealth & Development Office states it is aware of seven British nationals who died in Turkey in 2025 following medical procedures. In a March 2024 Commons debate, a minister put the total at 28 British nationals dead since 2019 after elective procedures there. Research in BMJ Open found NHS costs reaching £20,000 per patient when complications from overseas cosmetic and bariatric surgery come home. Around 348,000 UK residents travelled abroad for treatment in 2022, on ONS estimates.
Westminster cannot regulate a clinic in Bangkok, so its response has been communications. In August 2025 the Department of Health and Social Care partnered with TikTok to run warnings through medical influencers. Health minister Karin Smyth said too many people were being left with life-altering injuries after going abroad for medical procedures
, and pointed at deals that look too good, promoted by influencers who have never visited the clinic.
The marketing layer of medical travel now runs on personal recommendation from people with audiences. The safety layer runs on accreditation bodies that audit hospitals. The two systems never touch.
The FCDO’s Thailand travel advice carries no death figure of the kind attached to its Turkey page.
Why it matters
Medical tourism’s safety architecture was built for a patient who plans. Someone who compares accreditation, books through a facilitator, flies in for a procedure and stays for follow-up.
Ubiribo was not that patient, and a growing share of the people this sector actually serves are not either. He was already in the country. The decision appears to have been made mid-trip. The procedure took under an hour. There was no facilitator to vet the provider, no seal to check, no pre-operative workup for a man who would be on a massage table within the hour.
JCI, ISO, country rankings, hospital league tables, medical visa schemes: every trust signal the sector has built operates above the level where this happened. No accreditation scheme inspects the walk-in aesthetic clinic. No ranking lists it. No directory verifies it. That is where a large and rising share of cross-border cosmetic spending now goes.
The same structure exists wherever a strong, audited hospital tier sits above a cheap, socially marketed aesthetic tier. Istanbul and Seoul are the clearest parallels.
What to watch
- The coroner’s full findings. A Prevention of Future Deaths report would carry more weight than any press account of the hearing. Watch whether the coroner widens scope to elective procedures abroad, as a UK coroner did in the 2023 Hayley Dowell case.
- Thai regulatory action. Whether the Department of Health Service Support opens or discloses an inquiry, and whether the clinic is named.
- FCDO travel advice. Any addition of medical-procedure language to the Thailand health section would mark a shift in how the UK government treats the destination.
- Insurance exclusions. Most travel policies already void cover for elective cosmetic treatment undertaken mid-trip. Underwriters tighten wording faster than regulators write rules, and that wording is where patients will feel this first.
- Whether Thai hospital groups say anything. They have a direct commercial interest in separating their tier from the unaccredited one. Silence is a choice.
